Champions Oncology Inc

CSBR

Company Profile

  • Business description

    Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

  • Contact

    One University Plaza
    Suite 307
    HackensackNJ07601
    USA

    T: +1 201 808-8400

    E: [email protected]

    https://www.championsoncology.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2026

    Employees

    306

Stocks News & Analysis

stocks

ASX healthcare giant remains well positioned despite share slump

We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks

Australian bank remains overvalued despite strong result

When strong fundamentals meet persistent valuation headwinds.
stocks

Chart of the Week: Soft earnings growth outlook for Australian banks

The latest take from our equity research analysts.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8041.30-0.44%
CAC 408,401.8088.561.07%
DAX 4025,200.48344.331.39%
Dow JONES (US)50,302.41181.010.36%
FTSE 10010,471.560.55-0.01%
HKSE27,032.54233.84-0.86%
NASDAQ23,139.7873.310.32%
Nikkei 22557,639.8410.70-0.02%
NZX 50 Index13,531.4824.200.18%
S&P 5006,963.7822.310.32%
S&P/ASX 2009,043.5018.50-0.20%
SSE Composite Index4,134.022.030.05%

Market Movers